Prescription of silibinin-n-methylglucamine drop pills and preparation process thereof

A technology of silybin and meglumine salt, which is applied in the field of drugs for the treatment of acute and chronic hepatitis, and can solve the problem of affecting drug dissolution and bioavailability, unreasonable silymarin tablets, and slow dissolution of Yiganling tablets and other issues, to achieve the effect of improving bioavailability, facilitating absorption, and low cost

Inactive Publication Date: 2006-12-13
孙民富
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After compression molding, the dosage form itself has problems affecting the dissolution rate and bioavailability of the drug, which seriously affects the efficacy of the drug.
Some literatures have studied the dissolution rate of Yiganling tablets, and t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0026] Take 25g of silibinin meglumine salt, mix it with 75g of polyethylene glycol 4000 in a container, and heat until the matrix dissolves; transfer the above molten liquid to the liquid storage tank in a vacuum state of the dropping pill machine, and keep it warm at 75°C 30 minutes; Add simethicone oil into the cooling column, the outlet temperature of the condensate is 10°C; the inner diameter of the dripper is 3mm, the outer diameter is 5mm; the molten liquid is dripped into the condensate at a rate of 30 drops per minute, and collected Dropping pills are obtained by screening and drying.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating acute and chronic hepatitis and process for preparation, wherein the medicament is prepared from silibinin-N-methylglucamine as the main constituent, and right mxtrix through a predetermined processing combinations. Compared with the existing dosage forms, the drop pill preparation has the advantages of short technological process, low cost of production and quick-effectiveness.

Description

(1) Technical field [0001] The invention belongs to the technical field of medicines for treating acute and chronic hepatitis, in particular to a formula and a preparation process of a drop pill preparation for treating acute and chronic hepatitis. (2) Background technology [0002] Yiganling Tablets are listed in the Chinese Ministry of Health’s standard Chinese medicine preparations. They are unilateral preparations of silymarin. Because it can improve liver function and protect liver cell membranes, it has been used as a liver-protecting drug for acute and chronic hepatitis for many years. and persistent hepatitis. According to investigations, the current sales volume of the drug is relatively low, mainly because silymarin itself is an insoluble flavonoid compound, but it is made into a tablet form. The preparation process of the tablet is that the silymarin, starch and dextrin are uniformly mixed to form granules, dried and pressed into tablets. After compression moldi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/357A61K9/20A61P1/16A61P31/14
Inventor 孙民富
Owner 孙民富
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap